| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |